BTAI icon

BioXcel Therapeutics
BTAI

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$7
185% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
29% 1-yr BTAI win rate
15 Sep ‘25 1 month ago
Mizuho
Mizuho
Graig Suvannavejh
12 Sep ‘25 1 month ago